|
|
Volumn 772, Issue 2, 2002, Pages 317-325
|
|
Validation of a liquid chromatographic-tandem mass spectrometric method for the measurement of (R)-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1, 4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea (YF476) in human plasma
|
|
Author keywords
Benzodiazepines; YF476
|
|
Indexed keywords
ATMOSPHERIC PRESSURE;
BODY FLUIDS;
CALIBRATION;
IONIZATION;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
CLINICAL STUDIES;
BIOMEDICAL ENGINEERING;
1 [2,3 DIHYDRO 2 OXO 1 PIVALOYLMETHYL 5 (2 PYRIDYL) 1H 1,4 BENZODIAZEPIN 3 YL] 3 [3 (METHYLAMINO)PHENYL]UREA;
CARBON;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
ATMOSPHERIC PRESSURE;
CALIBRATION;
CHEMICAL REACTION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
HUMAN;
IONIZATION;
LIQUID CHROMATOGRAPHY;
LIQUID LIQUID EXTRACTION;
MEASUREMENT;
PLASMA;
PRIORITY JOURNAL;
SENSITIVITY AND SPECIFICITY;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
ANIMALS;
BENZODIAZEPINONES;
CALIBRATION;
DOGS;
HALF-LIFE;
HORMONE ANTAGONISTS;
HUMANS;
PHENYLUREA COMPOUNDS;
RATS;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0037024133
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/S1570-0232(02)00118-6 Document Type: Article |
|
Times cited : (9)
|
|
References (13)
|
